Dihydroquercetin attenuates lipopolysaccharide-induced acute lung injury through modulating FOXO3-mediated NF-κB signaling via miR-132–3p
Publication date: October 2020Source: Pulmonary Pharmacology & Therapeutics, Volume 64Author(s): Jian-Hua Liu, Liang Cao, Chang-Hong Zhang, Chen Li, Zhi-Hua Zhang, Qi Wu
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: Drugs & Pharmacology | Respiratory Medicine